AURKA and neoplasm: Aurora kinase A inhibition by MK-5108 and alisertib increases the anti-tumor activity of docetaxel, paclitaxel, and vincristine [27, 48, 51, 64–66], whereas Aurora A overexpression increases resistance to taxol [67].